Gene therapy may be ‘one-shot stop’ for rare bone disease

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must be delivered by injection three to six times each week.

Leave A Comment

Your email address will not be published. Required fields are marked *